surpass trial tirzepatide Diabetes Distilled: “Twincretin” significantly SURPASSes comparator effects on glucose, weight and quality of life SURMOUNT-1 Trial - Cardionerds Twitter
Description
Online Doctor & Online Pharmacy
Conclusions Patients with T2D starting tirzepatide had greater HbA1c and weight reductions at 12 months post-initiation than those on injectable semaglutide, regardless of previous GLP-1 RA use, consistent with previous clinical trial results.
Get clear answers on fluid changes, early side effects, and medical guidance
Call (720) 828-8177 to see if you qualify.
Roswell, GA
Understanding how these medications work together helps inform treatment decisions with your healthcare provider
